## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `tesamorelin-muscle-loss`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `tesamorelin-muscle-loss` v2 · content_hash `1fc7c99e0fb6ccfb…` · thread_head genesis · 19 DIVs
- **thesis (c1):** In a secondary analysis of randomized trials, tesamorelin responders (visceral fat loss ≥8%) showed greater increases in trunk muscle density (1.56–4.86 HU) and lean muscle area (0.64–1.08 cm²) vs placebo after 26 weeks.
  - c2 [human/active] Meta-analysis of tesamorelin trials reported a mean lean body mass increase of 1.42 kg alongside visceral fat reduction.
  - c3 [human/active] An ongoing clinical trial (NCT06554717) is evaluating tesamorelin plus exercise for physical function and muscle health in adults with HIV.
  - c4 [anecdotal/active] Reddit users report lean mass preservation or modest gains alongside visceral fat loss when using tesamorelin in calorie deficits, often with improved recovery.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `tesamorelin-muscle-loss`
- **title:** Tesamorelin for Muscle Loss: Human Evidence on Lean Mass, Muscle Density, and the GH Axis
- **url:** https://miscsubjects.com/a/tesamorelin-muscle-loss
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:24.087Z
- **tags:** peptide, matrix

## Body

## What's breaking down
Muscle loss, or sarcopenia-like decline, often stems from reduced growth hormone (GH) signaling with age or illness. This lowers IGF-1, slowing protein synthesis while catabolic processes continue. Visceral fat accumulation adds mechanical and inflammatory stress that can further impair muscle quality. In HIV-related lipodystrophy, excess abdominal fat pairs with muscle fat infiltration and reduced lean area. Repair pathways lag behind breakdown when GH pulses weaken. Tesamorelin is discussed here because studies examine its effect on the GH axis and downstream tissue changes rather than symptom masking.

## Why Tesamorelin might help you
If your muscle loss involves low GH/IGF-1 activity or excess visceral fat, the logic chain runs like this. Tesamorelin stimulates the pituitary to release endogenous GH in a more physiologic pattern. That raises circulating IGF-1. Higher IGF-1 supports protein synthesis in muscle tissue. In people who respond with visceral fat reduction, CT scans showed measurable gains in trunk muscle density and lean muscle area over 26 weeks. Therefore, if visceral fat or poor muscle quality is part of your profile, the compound is studied for its potential to shift the balance toward tissue-level repair signals instead of only lowering fat mass.

Step 1: GH release increases. Step 2: IGF-1 rises in a pulsatile way. Step 3: Muscle protein turnover favors synthesis. Step 4: In responders, muscle fat decreases and lean area increases on imaging. This targets the regenerative side of the equation for the layers listed above.

## How these fit together
Single-compound focus. Tesamorelin maps directly to the GH axis and visceral fat layer. If your situation includes multiple degeneration layers, this agent addresses the endocrine and body-composition component. Other approaches would need separate evaluation for neural, sleep, or direct anabolic layers.

## What the evidence actually shows
Human data come from secondary analyses of randomized trials in adults with HIV and abdominal obesity. One key study (Adrian et al.) restricted analysis to tesamorelin responders who lost at least 8% visceral adipose tissue. Compared with placebo, these participants showed statistically significant increases in muscle density (1.56–4.86 Hounsfield units across trunk muscle groups) and lean muscle area (0.64–1.08 cm²). A later meta-analysis reported a mean lean body mass increase of 1.42 kg. An ongoing trial (NCT06554717) is testing tesamorelin plus exercise for physical function in HIV. No large human trials exist for primary sarcopenia in non-HIV populations. Animal data on muscle-specific outcomes with tesamorelin are not prominent in the reviewed sources. Reddit and X reports remain anecdotal.

## What scientists say
The authors of the 2019 Journal of Frailty & Aging paper conclude that among responders, tesamorelin increased skeletal muscle area and density. They note the changes occurred alongside visceral fat reduction and call for longer-term studies on functional impact outside HIV. Reviews emphasize that lean mass gains occur without proportional subcutaneous fat loss or major glycemic disruption in the studied cohorts. Researchers highlight that benefits appear tied to visceral fat responders rather than universal.

## What people say on Reddit
Users in peptide communities describe tesamorelin as helping preserve lean mass during calorie deficits. One post states: “Tesa is a tool that raises IGF-1 levels which can in turn preserves muscle mass in a calories deficit and potentially build lean muscle.” Another reports: “Even with zero exercise my lean muscle mass increased by about 15%, visceral fat reduction by 80%.” Several mention better recovery and visible muscle definition when combined with training, though scale weight often stays stable because fat loss offsets any lean gain. Experiences vary; some note waist reduction without overall weight change.

## What people say on X
Public posts on X referencing tesamorelin and muscle are sparse in current searches. Most discussion echoes the clinical focus on visceral fat reduction and secondary lean mass observations from the HIV trials. Anecdotal functional claims appear less frequently than on Reddit.

## What we do not know
Human evidence is concentrated in HIV populations with abdominal obesity. Direct trials in age-related sarcopenia or non-HIV muscle loss are absent. Long-term (>26 weeks) effects on muscle strength, physical performance, or fracture risk remain unmeasured in published data. Whether gains persist after stopping treatment is unknown. Interactions with resistance training protocols or other body-composition interventions need further controlled study. Effects on muscle in women or diverse ethnic groups are underrepresented.

## Safety and limits
Reported adverse events in trials include injection-site reactions, arthralgia, myalgia, and paresthesia. No major glucose dysregulation appeared in the meta-analysis. Human data are limited to specific responder subgroups and short-to-medium durations. Individual responses differ, and imaging changes do not automatically equal improved daily function. All observations come from controlled settings; real-world variability is higher.

## Claims (4)

- **c1** [human w=0.8] In a secondary analysis of randomized trials, tesamorelin responders (visceral fat loss ≥8%) showed greater increases in trunk muscle density (1.56–4.86 HU) and lean muscle area (0.64–1.08 cm²) vs placebo after 26 weeks.
  - who_claims: grok/grok-4.3
  - sources: s1
- **c2** [human w=0.8] Meta-analysis of tesamorelin trials reported a mean lean body mass increase of 1.42 kg alongside visceral fat reduction.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c3** [human w=0.8] An ongoing clinical trial (NCT06554717) is evaluating tesamorelin plus exercise for physical function and muscle health in adults with HIV.
  - who_claims: grok/grok-4.3
  - sources: s3
- **c4** [anecdotal w=0.3] Reddit users report lean mass preservation or modest gains alongside visceral fat loss when using tesamorelin in calorie deficits, often with improved recovery.
  - who_claims: grok/grok-4.3
  - sources: s4, s5

## Voxel graph (4 atoms · 9 edges)
- full graph: https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (5)
- chain valid: yes · head: `500a99f3722c7580`

### s1 · pubmed · ok
- title: The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV
- url: https://pubmed.ncbi.nlm.nih.gov/31237318/
- summary: Secondary analysis of two RCTs; CT-based muscle metrics in responders.
- quote: tesamorelin was effective in increasing skeletal muscle area and density
- claim_ids: c1
- hash: `b0762e1a20bcb7ca`

### s2 · pubmed · ok
- title: A meta-analysis of randomized controlled trials
- url: https://pubmed.ncbi.nlm.nih.gov/41545261/
- summary: Pooled body composition outcomes from tesamorelin trials in HIV lipodystrophy.
- quote: A significant increase in lean body mass was observed (MD=1.42 kg, 95% CI [1.13, 1.71]; P < 0.001)
- claim_ids: c2
- hash: `96428706c2883c39`

### s3 · clinical_trial · ok
- title: Tesamorelin as an Adjunct to Exercise for Improving Physical Function and Muscle Health in Adults With HIV
- url: https://clinicaltrials.gov/study/NCT06554717
- summary: Active trial combining tesamorelin with exercise.
- quote: learn whether the medication tesamorelin will improve physical function and muscle health
- claim_ids: c3
- hash: `3efea45c7c0c600b`

### s4 · reddit · ok
- title: Tesamorelin Belly Fat Reduction
- url: https://www.reddit.com/r/USPeptides/comments/1p3bh79/tesamorelin_belly_fat_reduction_growth_hormone/
- summary: User discussion on muscle preservation.
- quote: Tesa is a tool that raises IGF-1 levels which can in turn preserves muscle mass in a calories deficit
- claim_ids: c4
- hash: `29bc4fe1e1f6416b`

### s5 · reddit · ok
- title: Starting Tesamorelin
- url: https://www.reddit.com/r/Biohackers/comments/1qlnwf7/starting_tesamorelin_next_week_advice_needed/
- summary: Self-reported body composition changes.
- quote: Even with zero exercise my lean muscle mass increased by about 15%
- claim_ids: c4
- hash: `500a99f3722c7580`

## Provenance (2 model passes)
- chain valid: yes · head: `19fbfa92b36bdaf0`

- write · grok/grok-4.3 · 2026-06-29T23:19 · hash `b893f8d91bcf`
- voxel_divide · owner · 2026-07-17T02:42 · hash `19fbfa92b36b`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tesamorelin-muscle-loss","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tesamorelin-muscle-loss|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tesamorelin-muscle-loss|tier|assertion`
- **iMessage ask:** `tesamorelin-muscle-loss|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `tesamorelin-muscle-loss`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*